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Abstract Sex hormones have some implications on
headaches. The objective of the study was to investigate
the effects of hormonal changes comparatively on tension-
type headache (TTH) and migraine, in a population-based
sample. A nationwide face-to-face prevalence study was
conducted using a structured electronic questionnaire.
54.3 % of the migraineurs reported that the probability of
experiencing headache during menstruation was high,
whereas 3.9 % had headache only during menstruation.
Forward logistic regression analysis revealed that men-
struation was a significant trigger for migraine in com-
parison to TTH. On the other hand, nearly double the
number of TTH sufferers reported ‘‘pure menstrual head-
ache’’ compared to migraineurs (p = 0.02). Menstrual
headaches caused significantly higher MIDAS grades. One-
third of the definite migraineurs reported improvement
during pregnancy and oral contraceptives significantly
worsened migraine. Menopause had a slight improving
effect on migraine compared to TTH. Sex hormonal
changes have major impacts particularly on migraine;
however, the effects of hormonal fluctuations on TTH
should not be underestimated.
Keywords Sex hormones  Headache  Migraine 
Tension-type headache  Menstruation  Menopause
Introduction
The obvious difference in pain prevalence related to gender
is well known, but the underlying mechanisms are not
clearly identified. Female sex steroids may play an
important role in this difference. The most important sex
hormones, estrogen and progesterone, influence peripheral
and central pain transmission via serotonergic, noradren-
ergic, glutamatergic, GABAergic and opioidergic neuro-
transmitter systems [1, 2].
Headache is among the most prevalent and disabling
disorders and pain syndromes [3, 4]. Epidemiological data
in different populations have clearly shown that headache
was more prevalent in women compared to men [4]. This
difference is best visible in migraine, and migraine prev-
alence is more than doubled in women [4]. Migraine
prevalence does not differ between genders before ado-
lescence. However, a significant prevalence increase
occurs in females compared to males after menarche [5–8],
and this point inevitably leads to the hypothesis that female
Turkish Headache Prevalence Study Group is given in Appendix 2.
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sex hormones play a crucial role in migraine pathophysi-
ology [2, 9]. Many studies investigating this intriguing
relationship between migraine and hormonal changes in
women, i.e., menstruation, menopause, pregnancy and use
of oral contraceptives (OCs), have shown some support for
this hypothesis [10–17]. As a result, in 2004, the Interna-
tional Headache Society (IHS) proposed the diagnostic
criteria for pure menstrual and menstrual-related migraine
without aura in the appendix of the second edition of the
International Classification of Headache Disorders (ICHD-
2) [18].
On the other hand, studies investigating the relationship
between tension-type headache (TTH) and hormonal chan-
ges are limited. The results of these studies were contradic-
tive: some indicated similar findings like migraine, while
some others reported no significant associations between
hormonal changes and TTH [10–14, 17, 19]. Interestingly
Arjona et al. [20] suggested a new term ‘‘menstrual TTH’’,
a description which was only used for migraine before-
hand. Although, there is some data suggesting a relation-
ship between hormonal changes and TTH, no consensus
has been reached so far about the role for sex hormones in
TTH pathophysiology. This gap might probably prevent us
from investigating the possible additional role of hormonal
mechanisms in TTH pathophysiology and establishing a
link between TTH and migraine in relation to female sex
hormones [21].
In this face-to-face, cross-sectional, population-based
study of 2,600 women, we aimed to investigate the effects
of sex hormonal changes both on TTH and migraine
comparatively for the first time in Turkey, a country
located between Asia and Europe with a different cultural
background.
Methods
We designed a nationwide, community-based prevalence
study in adults aged between 18 and 65 years, with face-to-
face interviews by 33 specially trained general practitioner
physicians using a structured electronic questionnaire. The
involved general practitioners received a 2-day long
training on headache before the study. The comprehensive
interview form included all diagnostic questions based on
the ICHD-2 criteria [18] for diagnoses of migraine and
TTH within the last year. Definite TTH was diagnosed if
the participants were not diagnosed with ‘‘definite’’ or
‘‘probable’’ migraine and fulfilled all TTH criteria. Women
suffering from both migraine and TTH were classified as
having migraine. By definition, the TTH group consisted
only of pure TTH sufferers for our study purposes. ICHD-2
criteria were the case definition criteria for the diagnoses of
definite and probable TTH and migraine. Ten dedicated
questions about sex hormonal changes and relationship
with headache were included in the questionnaire, which
the female subjects were asked (Appendix A). The vali-
dated Turkish version of the Migraine Disability Assess-
ment (MIDAS) Questionnaire was also applied to all
relevant subjects with headache.
The study design has been described elsewhere in detail
[22]. Briefly, a multi-stage sampling method was used. In the
first stage, 21 cities were selected representing the charac-
teristics of households in all seven geographical regions of
Turkey based on the ratio of their population to the total
population of Turkey in the year 2008, according to the
Turkish Statistical Institute (http://report.tuik.gov.tr/reports/
rwservlet?adnksdb2=&ENVID=adnksdb2Env&report=tur
kiye_yasgr.RDF&p_yil=2008&p_dil=1&desformat=html).
In the second stage, the distributions of urban and rural
populations, gender and age groups were all taken into
account to choose the target population in these cities, to
ensure that there would be no selection bias; 6,000 house-
holds were chosen with an acceptable error rate of ±1.3 %.
With the guidance of the quotas for each city, the houses to be
visited were determined using a simple random-sampling
method in districts, streets and rural areas. Only one person
was interviewed in each household to avoid any bias. A Kish
sampling grid was used to select one person per household to
be interviewed. A total of 6,000 households were visited.
After excluding the households visited but not interviewed
because of several reasons such as ‘‘refusing to be inter-
viewed’’, ‘‘having no time’’, ‘‘non-presence at home’’, etc.,
89 % of the households had valid interviews. In the end, the
statistical standard error was ±1.3 % within a confidence
interval of 95 % for 5,323 interviews, as planned. The study
was completed within 3 months in the year 2008.
The menstruation period was accepted as 3 days before
and 5 days after the beginning of menstruation similar to
some other studies [23–25]. We believe that this broader
range for the time window would have provided a more
reliable data acquisition in a retrospective study and there
are many patients reporting this broader period for men-
strual aggravation in our clinical experience. Furthermore,
due to the lack of a definition of menstrual TTH, except in
the Arjona et al.’s study [20], the same time window was
also used for TTH.
We asked the subjects to evaluate the course of their
headaches during menstruation, menopause, pregnancy and
OC intake as follows: disappeared, decreased (decreased
C50 % in frequency), no change, worsened; do not
remember; do not want to answer. Subjects were instructed
to evaluate the impact of hormonal changes and pregnan-
cies on their headaches as an overall impact throughout
their life and considering all pregnancies.
We tried to figure out a hormonal impact modeling of
TTH and migraine by evaluating the impact of hormonal
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situations on headaches. Therefore, we evaluated the like-
lihood of (1) experiencing headache during menstruation,
(2) improving effect of pregnancy and (3) menopause as
well as (4) the worsening effect of OCs on headache and
analyzed the answers in 11 possible statistical combina-
tions (for example, risk of experiencing headache during
menses ? worsening effect of OCs or the former two ?
improving effect of pregnancy, etc.). The relationship
between these variables was entered in the model and the
dependent variables, which were migraine and TTH, were
analyzed. We tried to predict the likelihood of diagnosis by
this modeling.
SPSS 15 software statistical package (SPSS Inc., Chicago,
IL, USA) was used for statistical analysis. Those patients
who did not want to answer the questions were excluded
from further analysis. Shapiro–Wilk test was used as the
normality test. Continuous variables were compared using
Mann–Whitney U test and Kruskal–Wallis test when the
data were not normally distributed. The categorical vari-
ables were analyzed by Pearson Chi-square, Yates’ conti-
nuity correction and Fisher’s exact test, where appropriate.
Among patients with migraine and TTH, a forward logistic
regression analysis was employed to examine the inde-
pendent sex hormonal predictors of headache as explained
above. A p value\0.05 was considered as significant. The
odds ratio was used as a measure of relative risk and the
associated 95 % confidence intervals [CI] were also
calculated.
Results
A total of 5,323 participants (2,600 (48.84 %) women)
were interviewed. The ages of participants ranged between
18 and 65 with a mean of 36.2 ± 12 years for women. The
details of this previous epidemiological study have been
published elsewhere [22].
A total of 640 women were diagnosed with definite
migraine and 349 with probable migraine (989 total
migraine; definite ? probable), whereas 116 had definite
TTH and 228 had probable TTH diagnosis (344 total;
definite ? probable).
Menstruation and headache
Of the total migraineurs, 722 (73.0 %) reported that they
still had menstrual cycles, whereas 115 individuals
(11.63 %) did not want to answer. Of the total TTH suf-
ferers, 233 (67.7 %) reported that they were still men-
struating, whereas 64 subjects did not want to answer. The
number of subjects still menstruating in both migraine and
TTH groups was similar (p = 0.525). Subjects currently on
OCs were included in the analyses.
The comparison between total migraine and total TTH
groups (‘‘yes’’ and ‘‘sometimes’’ were evaluated together)
showed that the migraine group had an increased probability
of experiencing a headache attack during menstruation
(p \ 0.001) (Table 1). The odds ratio of ‘‘highly likely’’
experiencing headache (in reference to no) in migraineurs
was 3.12 (95 % CI: 2.14–4.54) when compared with TTH
sufferers (see online supplementary files for further details).
Forward logistic regression analysis revealed that the
probability of experiencing headache during menstruation
was significantly higher (p = 0.006, OR = 2.79 95 % CI:
1.33–5.85) in migraineurs.
When total migraineurs were compared with total TTH
sufferers, migraineurs reported significantly more different
headaches during menstruation than the usual ones
(p \ 0.001) (Table 1) (see online supplementary files for
further details).
Only 32 (4.4 %) out of 722 menstruating migraineurs
(total) and 19 (8.2 %) out of 233 menstruating TTH suf-
ferers (total) reported pure menstrual headaches (Fig. 1)
(p = 0.032).
Table 1 The probability of experiencing a headache attack during menstruation and similarity to non-menstrual headaches
Headache type Most of the time n (%) Sometimes n (%) Never n (%) Different n (%) Similar n (%)
Definite migraine 252 (54.3 %) 90 (19.4 %) 122 (26.3 %) 158 (46.2 %) 184 (53.8 %)
Probable migraine 94 (36.4 %) 62 (24.0 %) 102 (39.5 %) 70 (44.9 %) 86 (55.1 %)
Total migraine 346 (47.9 %)* 152 (21.1 %) 224 (31.0 %) 228 (45.8 %)** 270 (54.2 %)
Definite TTH 23 (27.7 %) 29 (34.9 %) 31 (37.3 %) 11 (21.2 %) 41 (78.8 %)
Probable TTH 28 (18.7 %) 50 (33.3 %) 72 (48.0 %) 22 (28.2 %) 56 (71.8 %)
Total TTH 51 (21.9 %) 79 (33.9 %) 103 (44.2 %) 33 (25.4 %) 97 (74.6 %)
The comparisons were made between most of the time ? sometimes against never (Pearson Chi-square, Yates’ continuity correction and
Fisher’s exact tests were used where appropriate)
The menstrual period was defined as 3 days prior to and 5 days after the beginning of menstruation
Similarity of the menstrual headache was compared to the usual headaches outside the menstruation period as shown in the last two columns (%)
* p \ 0.001; compared to total TTH
** p \ 0.001; compared to total TTH
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Pregnancy and headache
A total of 450 definite and 221 probable migraineurs
reported that they had given birth to a child, whereas 78
definite and 120 probable TTH sufferers had given birth.
The available information on the course of headache during
pregnancy is shown in Table 2. Improvement and wors-
ening of headaches were both significantly more frequent
in the migraine group during pregnancy (Table 2) (see
online supplementary files for further details). The OR for
disappearance of headache (in reference to no change) in
migraineurs during pregnancy was 2.56 (95 % CI:
1.53–4.29) in comparison to the TTH sufferers.
OC use and headache
A total of 117 definite and 58 probable migraineurs
reported that they were currently on OCs or that they
previously had used OCs. Both current and past OC users
were included in the analyses. 16 definite and 34 probable
TTH sufferers were either on OCs or had used OCs. The
ratio of subjects reporting that they used OCs was similar
between the headache groups and thus allowed healthy
comparisons. The worsening effect of the OCs on migraine
was significant when compared with TTH and the
improvement rates were low, but similar between the
groups. The details of the analyses are shown in Table 3
(see online supplementary files for further details).
Menopause and headache
A total of 85 definite and 48 probable migraineurs and 19
definite and 22 probable TTH sufferers reported that they
were in menopause. The distribution of the subjects in
menopause did not show significant difference between the
headache subgroups (p = 0.620). Menopause had a slight
improving effect on migraine compared to TTH (p =















































































*p=0.032 (Yates’s continuity correction test); Total menstrual TTH
 compared to total menstrual migraine. 
Fig. 1 Pure menstrual headaches among migraine and tension-type
headache patients
Table 2 The course of headache during pregnancy (’?’ also contains
those patients reporting decreased headaches after the 3rd month of
pregnancy)
Headache type Improved ? Worsened No change
Definite migraine 162 (57 %) 31 (11 %) 91 (32)
Probable
migraine
52 (46 %) 15 (13.3 %) 46 (40.7 %)
Total migraine 214 (53.9 %)* 46 (11.6 %)** 137 (34.5 %)
Definite TTH 12 (34.3 %) 1 (2.9 %) 22 (62.9 %)
Probable TTH 26 (42.6 %) 3 (4.9 %) 32 (52.5 %)
Total TTH 38 (39.6 %) 4 (4.2 %) 54 (56.3 %)***
Pearson Chi-square, Yates’ continuity correction and Fisher’s exact
tests were used where appropriate
* p \ 0.001, compared to total TTH
** p = 0.036 compared to total TTH
*** p \ 0.001 compared to total migraine
Table 3 The course of headache during oral contraceptive use
Headache type Disappeared Decreased Total improvement
(disappeared ? decreased)
Worsened No change
Definite migraine (n = 117) 3 (4.0 %) 7 (9.5 %) 10 (13.5 %) 27 (36.5 %) 27 (36.5 %)
Probable migraine (n = 58) 3 (7.0 %) 2 (4.7 %) 5 (11.6 %) 12 (27.9 %) 21 (48.8 %)
Total migraine (n = 175) 6 (5.2 %) 9 (7.7 %) 15 (12.8 %) 39 (33.3 %)* 48 (41.0 %)
Definite TTH (n = 16) 1 (12.5 %) 0 1 (12.5 %) 0 (0 %) 6 (75.0 %)
Probable TTH (n = 34) 1 (5.0 %) 1 (5.0 %) 2 (10.0 %) 1 (5.0 %) 15 (75.0 %)
Total TTH (n = 50) 2 (7.1 %) 1 (3.6 %) 3 (10.7 %) 1 (3.6 %) 21 (75.0 %)**
Pearson Chi-square, Yates’ continuity correction and Fisher’s exact tests were used where appropriate
* p B 0.001; Compared to total TTH
** p B 0.001; Compared to total migraine
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Sex hormonal impact modeling for headaches
The reported risk of experiencing headache during
menstruation, impact of pregnancy, menopause and OCs
on headaches and pure menstrual headache were all
found to be significantly different in univariate analyses
done between TTH and migraine groups as reported
above, and a following forward logistic regression anal-
ysis showed that the only hormonal situation that was
significantly different between the two headache types
was the risk of experiencing headache during menses
(p = 0.006, OR = 2.79 (95 % CI: 1.33–5.85), B =
1.028). All other significant differences in univariate
analysis did not reach a significance level in multivariate
analysis.
After analyzing these various effects of sex hormonal
changes on headache, we tried to figure out whether we
could come out with a hormonal impact modeling of
migraine and TTH. In all combinations, those reporting
high risk of experiencing headache during menses and
worsening of headache during OC use were significantly
higher in migraineurs compared to TTH sufferers
(p = 0.003). The positive predictive value of this specific
combination of hormonal changes for migraine is 28.9 %,
which is very low. All other hormonal situations’ impact
combinations were not significant.
The effect of menstrual headaches on MIDAS
We further analyzed the relationship between the risk of
experiencing headache during menstruation and MIDAS
grade as an outcome. All primary headache sufferers
(migraine and TTH), experiencing (highly likely or
sometimes) headache during menstruation had significantly
higher MIDAS grades (p \ 0.001) (Mann–Whitney U test).
The separate analysis revealed the same result for migraine
(p \ 0.001), but not for TTH (p = 0.711) (Table 4).
Discussion
We conducted a comparative investigation of sex hormonal
milestones which might have an impact on both migraine
and TTH, in the same population-based retrospective
study. Our results revealed that sex hormonal changes
affected migraineurs more frequently than TTH sufferers
as expected [19, 26–29]. One of the novel and interesting
results of this study was that significantly more TTH suf-
ferers reported headaches limited to the menstrual period,
even though more migraineurs in general reported head-
ache aggravation during menstruation. Oral contraceptive
pills had a significant worsening effect on migraine,
whereas the impact of pregnancy was more prominent on
migraine in both ways (improving and worsening). Men-
opause, on the other hand, had an improving effect on
migraine.
Menstruation and headache
Of all female migraineurs, 54.3 % reported that they were
highly likely to experience headaches during menstruation.
It was remarkable that migraine attacks during menstrua-
tion had a significant relationship with worsened overall
*p=0.046  compared to TTH total 
(Pearson chi-square, Yates’s continuity correction and Fisher’s exact tests
were used where appropriate) 
Fig. 2 Course of headache during menopause
Table 4 The relationship between experiencing headache during















Yes No Yes No Yes No
n 498 224 130 103 642 343
Median MIDAS grade 1* 1 1 1 1** 1
IQR 2 1 0 0 1 0
The interquartile range (IQR) is a measure of statistical dispersion in
descriptive statistics, being equal to the difference between the upper
and lower quartiles, IQR = Q3-Q1
* p \ 0.001 (Mann–Whitney U test); compared to migraineurs
without menstrual migraine headaches
** p \ 0.001 (Mann–Whitney U test); compared to without menstrual
headaches
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MIDAS grade (p \ 0.001). Some studies reported that
migraine attacks during menstruation were more severe
and longer than the usual attacks occurring at other times
[30–32]. We speculate that this severity or altered per-
ception of the migraine attack during menstruation might
lead to worsened disability. Furthermore, our findings
clearly indicate that headache caregivers should focus on
the menstrual migraine attacks and treat them more vig-
orously. Better management of migraine attacks during
menstruation might provide much more benefit on the
outcome than expected.
Almost all studies reported that menstruation was a very
strong trigger, both for migraine and TTH [8, 11, 12, 17,
20, 26]. Rasmussen et al. [10] indicated that significantly
more TTH sufferers reported menstruation as a trigger for
headache when compared with migraineurs, whereas some
headache center-based studies contradicted this finding
[19] or other population-based studies reported that men-
struation appeared to be a risk factor in similar frequencies
both for migraine and TTH [11]. This discrepancy is
probably related to the methodological differences, the
source of the study groups or the presence of mixed
headache groups. In our study, definite and probable TTH
groups included only pure TTH sufferers as the subjects
were diagnosed with TTH after the subjects with migraine
diagnosis were excluded. More than half of TTH sufferers
as well as three-fourths of all migraineurs reported that
they experienced headache during menses. Forward logis-
tic regression analysis revealed that menstruation was a
significantly higher trigger factor for migraine in compar-
ison to TTH. We showed that menses was not a specific,
but a very frequent triggering factor for female migraineurs
in the general population. Furthermore, migraineurs
reported that the headaches they experienced during men-
struation had different characteristics than the usual ones
(mostly increased severity during menstruation) (p \
0,001, compared to TTH). On the other hand, more than
25 % of TTH sufferers also reported different headaches
during menses.
There is limited data on menstrual migraine (MM)
prevalence. Couturier et al. [33] reported MM prevalence
to be 3 % in the general population. In our study, MM
prevalence was slightly higher (4.4 %). However, our
menstrual period was defined to be longer (-3, ?5 days of
menstruation) than that they had reported (-2, ?3).
Another study by mail questionnaires included women
aged 30–44 years in Norway, and pure MM and menstru-
ally related migraine prevalences were 2.7 and 4.6 %,
respectively [34]. Age differences, study design as inter-
view versus questionnaire and climatic or sociocultural
differences might have resulted in a lower prevalence rate
of pure MM in Norway [34].
One of the most remarkable results of this study was the
higher frequency of pure menstrual headache in TTH suf-
ferers as shown in Fig. 1. Arjona et al. [20] proposed the
term ‘menstrual TTH’ for the first time. Our results sup-
ported their proposition and pure menstrual TTH might
actually be a prevalent and underestimated problem in the
female population. As much as 8.15 % of all TTH sufferers
experienced pure menstrual TTH in our population, which
is still lower compared to 28.5 % in the study (which was
outpatient clinic based) by Arjona et al. [20]. We speculate
that the mental and physical stress caused by menses make
the individual more prone to TTH. Further epidemiological
and pathophysiological studies investigating other aspects
and underlying mechanisms of this interesting relationship
between the menstruation and TTH should be planned in
the future.
Pregnancy and headache
Almost one-third of the definite migraineurs reported
improvement during pregnancy. Worsening effect of
pregnancy on migraine seemed to be higher than that on
TTH even if the logistic regression analysis did not
support this. The great majority of TTH sufferers were
not affected by pregnancy. It was already reported that
headaches had a tendency to diminish during pregnancy,
particularly in migraine, with a very wide improvement
rate of 18–80 % in different studies [10, 12, 13, 15, 19,
35–38]. All these studies had different methodologies
and different definitions of improvement, making them
difficult to compare. The most similar methodology to
ours was by Rasmussen et al. [10]. The improvement
rates among migraineurs (31.9 vs. 48 %) and TTH suf-
ferers (19.2 vs. 28 %) in our study were lower than that
reported [10]. It should be noted, however, that more
than 40 % of migraineurs and 50 % of TTH sufferers
were unable to remember the course of headache during
their pregnancies and this problem might have decreased
the improvement rates in our study. More than 50 % of
the remaining women reported improvement in migraine,
which is comparable to the study by Rasmussen et al.
[10]. Similar to the same study, significantly more mi-
graineurs reported improvement during pregnancy com-
pared to TTH (p = 0.003). On the other hand, the rate of
worsening was also higher for migraine and lower for
TTH (6.9 and 2.0 % respectively in our study) compared
to that reported by Rasmussen et al. [10]. Another ret-
rospective epidemiological study reported higher
improvement rate compared to ours [38]. Due to our
retrospective design, we could not investigate the dif-
ferences in the course of migraine between the first and
the following pregnancies.
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Oral contraceptives and headache
The worsening effect of OCs on migraine was reported
more than a decade ago by Cupini et al. [15]. However,
there is still a great discrepancy on the relationship of OC
use and headache in the relevant literature [15, 37]. In some
population-based studies, no difference was found regard-
ing the prevalence of migraine or TTH related to the use of
OCs [10–12], whereas another prospective population-
based study showed that 3–5 % of women experienced
worsening of migraine [39]. In a population-based study in
Croatia, OCs were reported among the precipitant factors
of both migraine and TTH with similar rates [11]. Machado
et al. reported slightly higher worsening ratio in migrai-
neurs [40]. Our results showed a prominent worsening
effect of OCs on migraine compared to TTH among the
present and previous users similar to the Head-Hunt study
[35]. The differences in the literature might reflect different
methodologies of the studies or different subgroups of
migraineurs, but there could also be some different socio-
cultural perceptions about the use of OCs in different
populations.
Menopause and headache
Migraine sufferers reported a significant decrease in
headache frequency during menopause in comparison to
TTH sufferers. Only 17.3 % of the migraineurs reported
improvement during menopause, but the number of eval-
uated subjects with migraine in menopause was somewhat
low (n = 113) in our study because of the subjects who
could not recall the real effect. Neri et al. reported an
improvement in almost 2/3 of migraineurs, whereas head-
ache worsened or did not change in 70 % of TTH subjects
[14]. Likewise, in our study worsened or unchanged
headaches were about 73 % in our TTH subjects; but the
improvement rate of migraine was significantly lower
compared to this study [14]. Furthermore, in another pop-
ulation-based study, no significant association was reported
between migraine and menopause in women aged between
40 and 74 years [41]. As the population-based data con-
cerning the relation between TTH and menopause was very
limited, it was difficult to compare our data with other
studies.
There are several possible limitations of this study. First
of all, recall bias was the major limitation, which could be
expected in population-based retrospective studies. We
diagnosed the subjects with migraine and TTH during the
last year, whereas the questioned hormonal changes could
happen at any time or even many years before. We do not
exactly know if at that time the questioned subjects’
headache diagnoses were identical to those recorded during
the last year. Therefore, the results cannot be generalized to
the whole life period. The results should be evaluated with
caution only for a certain lifetime period, but not for whole
lifetime. Furthermore, our evaluation of the course of
subjects’ past headaches during different hormonal situa-
tions without objectively measuring hormonal levels might
have led to decreased objectivity. However, to our
knowledge this is the first population-based epidemiologi-
cal study investigating the impact of major hormonal
fluctuations in women, both for migraine and also for TTH
comparatively. To date, only some of the sex hormonal
situations were investigated in population-based studies
and most of them were limited to migraine. Besides, those
studies investigating sex hormonal fluctuations are mostly
from North America and West Europe. Thus, there is a
definite need for epidemiological studies investigating
these issues in different populations, as the influence on
TTH and migraine across the world could vary from one
country to another. This first study investigating the rela-
tionship between sex hormones and headache in Turkish
women came from a different part of the world, which
reflected different sociocultural and demographic charac-
teristics. Face-to-face interviews and trained general prac-
titioner physicians performing these interviews increased
the power of our study in comparison to mailed question-
naires. The participation rate (89 %) was very satisfactory
for such a large epidemiologic study and higher than many
studies [10, 11, 16].
In conclusion; hormonal fluctuations appeared to have
an impact, at least to some degree, on migraine as well as
on TTH. Hormonal effects on TTH should not be under-
estimated, and there are a considerable number of women
having pure menstrual TTH. More experimental and clin-
ical studies are needed to evaluate the real effect of sex
hormones on TTH.
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Appendix 1
Questions about hormonal situations
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